Quest Diagnostics Reports Third Quarter 2017 Financial Results, Updates 2017 Financial Guidance and Reaffirms Long Term Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. JPM
5. ICLR
6. USO
7. FUL
8. LAES

Go back to Quest Diagnostics Reports Third Quarter 2017 Financial Results, Updates 2017 Financial Guidance and Reaffirms Long Term Outlook

Quest Diagnostics (DGX) PT Lowered to $103 at Mizuho Securities

October 19, 2017 5:19 PM EDT

Mizuho Securities lowered its price target on Quest Diagnostics (NYSE: DGX) to $103.00 (from $122.00) while maintaining a Buy rating. Analyst Ann Hynes updated 2018 and 2019 adjusted EPS estimates, both decreasing by $0.10 related to the proposed PAMA rule released in September.

Mizuho Securities did not... More

Quest Diagnostics (DGX) Tops Q3 EPS by 4c

October 19, 2017 6:48 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.39, $0.04 better than the analyst estimate of $1.35. Revenue for the quarter came in at $1.93 billion versus the consensus estimate of $1.92 billion.

GUIDANCE:

Quest Diagnostics sees FY2017 EPS of $5.62-$5.67, versus the consensus of $5.63. Quest... More